We previously reported a decline in tumour-associated macrophages (TAMs), defined as CD3-/CD19-/CD14 + /HLADR+ cells, CD206 and CD163 post-NACT in HGSOC patients and mouse models. The gene discussed is MRC1; the disease is neoplasm.